Hyaluronic acid also known as hyaluronan, hyaluronate or HA is a high molecular mass anionic polysaccharide present in fluid form in human body. Hyaluronic acid when to be used as medicine is extracted from rooster combs or produced from bacteria in laboratories. It is mostly used in treatment of knee osteoarthritis by injecting it into the patient’s knee joint and is also used for tissue healing post surgery. It acts as a lubricant in joints and other tissues and also helps in healing of injuries.
Browse Full Report With TOC: http://www.transparencymarketresearch.com/hyaluronic-acid-products.html
Hyaluronic acid products market is categorized on the basis of:
- One- injection
- Other joints
North America represents, both the largest and fastest-growing regional market for HA visco-supplementation due to increase in prevalence of obesity and growing aging population thus the resultant high prevalence of osteoarthritis. European countries and other emerging economies such as Brazil, Japan, India, China, Taiwan and South Korea are expected to show a significant growth in the global HA products market due to provision of cheaper treatment, improved reimbursement policies and increase in new product approvals.
Increase in the prevalence of disorders such as osteoarthritis and obesity is one of the major reasons driving the demand for hyaluronic acid products. Other factors responsible for fueling the hyaluronic acid products markets include exploring the use of hyaluronic acid in body joints other than knee such as shoulders and hips, increased patient compliance due to cost containment and shorter treatment regimens. Dicey reimbursement policies in developing areas of Europe and Asia and price competition amongst new market entrants may pose challenge to the hyaluronic acid products market.
Some of the key players in the hyaluronic acid products market include Anika Therapeutics, Inc., Bioniche Life Sciences, Inc., Bioventus LLC, Cadila Pharmaceuticals Ltd., DJO Global, Inc., Genzyme Corporation, Lupin Pharmaceuticals, Inc., Mylan, Inc., Sanofi S.A., Towa Pharmaceuticals Co., Ltd. and Uji Pharmaceutical Co., Ltd.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Medical Devices Markets: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207
Browse Market Research Blog: